Dihydromyricetin: A Multitarget Anticancer Agent Exhibiting Cytotoxic and Anti-Angiogenic Activities in Preclinical Models
These findings indicate that DMY is a multifunctional agent exhibiting both antiangiogenic and cytotoxic properties, warranting further preclinical and clinical investigation.
Authors
- GABRIELA DANTAS CARVALHO
- Athanara Alves de Sousa (ORCID: https://orcid.org/0000-0002-1106-4320)
- Boris Timah (ORCID: https://orcid.org/0000-0002-7298-9423)
- Guilherme Barroso L. De Freitas (ORCID: https://orcid.org/0000-0002-9525-848X)
- José Gabriel Fontenele Gomes (ORCID: https://orcid.org/0000-0001-6114-0726)
- Neirigelson Ferreira de Barros Leite (ORCID: https://orcid.org/0000-0001-6505-1368)
- João Marcelo de Castro e Sousa
- Bruno de Sousa Barbosa
- João Pedro Alves Damaceno do Lago
Institutions
- Universidade Estadual de Maringá (BR)
- Universidade Federal do Piauí (BR)
- Universidade Federal do Maranhão (BR)
Publication Details
- Journal
- Current Topics in Medicinal Chemistry
- Published
- 2026-01-08
- DOI
- https://doi.org/10.2174/0115680266398105251020100300
- Primary Topic
- Medicinal plant effects and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00